We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$11.8B
AUM Growth
+$5.07B
Cap. Flow
+$4.92B
Cap. Flow %
41.89%
Top 10 Hldgs %
13.22%
Holding
1,361
New
679
Increased
244
Reduced
170
Closed
248

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$74.7M
2
TSM icon
TSMC
TSM
+$65.2M
3
AZO icon
AutoZone
AZO
+$62.3M
4
BBY icon
Best Buy
BBY
+$56M
5
PM icon
Philip Morris
PM
+$54.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 23.25%
2 Healthcare 17.43%
3 Technology 12.56%
4 Financials 11.41%
5 Industrials 8.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INST
701
DELISTED
Instructure, Inc.
INST
$1.78M 0.02%
+50,339
New +$2.07M
HLI icon
702
Houlihan Lokey
HLI
$9.02B
$1.78M 0.02%
39,646
+17,557
+79% +$851K
ACBI
703
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$1.78M 0.02%
106,013
+94,073
+788% +$1.74M
STRL icon
704
Sterling Infrastructure
STRL
$16.7B
$1.77M 0.02%
+123,922
New +$1.76M
BPMP
705
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
$1.77M 0.02%
94,136
SIRI icon
706
SiriusXM
SIRI
$10.1B
$1.77M 0.02%
27,981
+20,178
+259% +$1.4M
HCC icon
707
Warrior Met Coal
HCC
$4.86B
$1.76M 0.02%
65,041
-24,359
-27% -$622K
BTE icon
708
Baytex Energy
BTE
$2.92B
$1.74M 0.01%
+600,900
New +$1.84M
DXC icon
709
DXC Technology
DXC
$1.73B
$1.72M 0.01%
18,396
-120,021
-87% -$10.6M
CAAP icon
710
Corporacion America
CAAP
$4.09B
$1.72M 0.01%
+201,295
New +$1.88M
NVRO
711
DELISTED
NEVRO CORP.
NVRO
$1.71M 0.01%
+30,018
New +$1.88M
ALL icon
712
Allstate
ALL
$67.5B
$1.7M 0.01%
17,202
-34,185
-67% -$3.33M
ZBH icon
713
Zimmer Biomet
ZBH
$18.4B
$1.69M 0.01%
+13,271
New +$1.58M
SXC icon
714
SunCoke Energy
SXC
$797M
$1.68M 0.01%
+144,763
New +$1.72M
BEDU
715
DELISTED
Bright Scholar Education Holdings
BEDU
$1.67M 0.01%
+33,772
New +$1.86M
MLAB icon
716
Mesa Laboratories
MLAB
$574M
$1.67M 0.01%
+9,012
New +$1.81M
CORT icon
717
Corcept Therapeutics
CORT
$12B
$1.64M 0.01%
+117,252
New +$1.64M
RYAAY icon
718
Ryanair
RYAAY
$31.3B
$1.64M 0.01%
+42,635
New +$1.75M
SABR icon
719
Sabre
SABR
$835M
$1.63M 0.01%
+62,503
New +$1.6M
DLB icon
720
Dolby
DLB
$5.79B
$1.62M 0.01%
+23,165
New +$1.55M
XBI icon
721
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$1.61M 0.01%
+16,845
New +$1.63M
NMRK icon
722
Newmark Group
NMRK
$2.63B
$1.6M 0.01%
+143,168
New +$1.86M
KEY icon
723
KeyCorp
KEY
$24.4B
$1.58M 0.01%
79,670
-2,226
-3% -$46.2K
SU icon
724
Suncor Energy
SU
$70.3B
$1.58M 0.01%
+40,750
New +$1.65M
INFN
725
DELISTED
Infinera Corporation Common Stock
INFN
$1.57M 0.01%
+215,681
New +$1.83M

Similar funds

Marshall Wace's Q3 2018 Portfolio in Review

As of Q3 2018, Marshall Wace held 1,361 positions worth $11.8B, up 76% from $6.68B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Marshall Wace deployed $4.92B of net new capital in Q3 2018, opening 679 new positions and adding to 244 existing holdings. Its largest new stake was Tractor Supply: 4,920,060 shares worth $89.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Activision Blizzard, an estimated $74.7M trimmed.

  • Marshall Wace's largest Q3 2018 buy was Tractor Supply: 4,920,060 shares worth $89.4M.
  • Marshall Wace added most to Zoetis in Q3 2018, an estimated $124M increase.
  • Marshall Wace's biggest Q3 2018 reduction was Activision Blizzard, cutting an estimated $74.7M.
  • Marshall Wace fully exited AutoZone in Q3 2018, selling an estimated $62.3M.
  • Marshall Wace's ten largest holdings make up 13% of its $11.8B portfolio in Q3 2018.
  • Marshall Wace opened 679 new positions and closed 248 in Q3 2018.
  • Marshall Wace's portfolio value rose 76% quarter-over-quarter to $11.8B.

Based on Marshall Wace's 13F filing for Q3 2018, filed 14 Nov 2018.